España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Vistagen Therapeutics
VTGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.60
0.05
1.96%
At close: -
$2.61
0.01000
0.38%
After Hours: 4:22 PM EDT
Get Report
Comment
Vistagen Therapeutics (VTGN) Forecast
News
Earnings
Vistagen Therapeutics (VTGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Vistagen Therapeutics (NASDAQ:VTGN) Stock
Vistagen Therapeutics Stock (NASDAQ: VTGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
VistaGen Therapeutics Q2 2025 GAAP EPS $(0.42...
Benzinga Newsdesk
Monday, September 23, 2024
Vistagen Initiates PALISADE-4 Phase 3 Study O...
Benzinga Newsdesk
Friday, September 06, 2024
All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy
Zacks
Tuesday, August 13, 2024
VistaGen Therapeutics Q1 2025 Adj EPS $(0.35)...
Benzinga Newsdesk
Tuesday, July 09, 2024
Vistagen Expands Global Intellectual Property...
Benzinga Newsdesk
Tuesday, June 11, 2024
Vistagen Reports FY24 Net Loss Of $(29.4)M Vs...
Benzinga Newsdesk
Thursday, April 25, 2024
Vistagen Announces Results From Phase 2A Pilo...
Benzinga Newsdesk
Monday, April 01, 2024
Vistagen Initiates PALISADE-3 Phase 3 Study O...
Benzinga Newsdesk
Monday, February 19, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, February 13, 2024
VistaGen Therapeutics Q3 EPS $(0.22) Beats $(...
Benzinga Newsdesk
Recap: Vistagen Therapeutics Q3 Earnings
Benzinga Insights
Earnings Scheduled For February 13, 2024
Benzinga Insights
Monday, February 12, 2024
VistaGen Therapeutics's Earnings: A Preview
Benzinga Insights
Wednesday, December 27, 2023
Vistagen Receives Notice From European Patent...
Benzinga Newsdesk
Thursday, December 07, 2023
Jefferies Upgrades Vistagen Therapeutics to B...
Benzinga Newsdesk
Hearing Vistagen Therapeutics Upgraded From A...
Charles Gross
Monday, December 04, 2023
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment
Vandana Singh
Tuesday, November 14, 2023
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst
Vandana Singh
Stifel Initiates Coverage On Vistagen Therape...
Benzinga Newsdesk
Thursday, November 09, 2023
VistaGen Therapeutics Q2 2024 EPS $(0.66) Bea...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Wednesday, November 08, 2023
VistaGen Therapeutics Earnings Preview
Benzinga Insights
Tuesday, November 07, 2023
Vistagen To Present Fasedienol Phase 3 Data A...
Benzinga Newsdesk
Tuesday, October 17, 2023
Why Vistagen Therapeutics Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, October 16, 2023
VistaGen shares are trading higher after a 13...
Benzinga Newsdesk
VistaGen Therapeutics 13G Filing Shows Citade...
Benzinga Newsdesk
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Point72 Asset Management, L.P. Holds 5.6% Pas...
Benzinga Newsdesk
Monday, October 02, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Vistagen Therapeutics Has Priced A $100M Unde...
Benzinga Newsdesk
Vistagen Therapeutics Also Planning To Initia...
Benzinga Newsdesk
Vistagen Therapeutics Plans To Launch The Pal...
Benzinga Newsdesk
Tuesday, September 12, 2023
Vistagen Announces Results from Exploratory P...
Benzinga Newsdesk
Monday, September 11, 2023
10 Short Squeeze Stocks To Watch: Getty Images, Bitcoin Depot, Blue Apron Holdings And More
Chris Katje
Tuesday, September 05, 2023
Maxim Group Maintains Buy on Vistagen Therape...
Benzinga Newsdesk
10 Short Squeeze Stocks To Watch: Blue Apron, Getty Images, Black Rifle Coffee And More
Chris Katje
Vistagen, Fuji Enter Exclusive Negotiation Ag...
Benzinga Newsdesk
Monday, August 28, 2023
10 Short Squeeze Stocks To Watch: Getty Images, Blue Apron, T Stamp, Black Rifle Coffee And More
Chris Katje
Tuesday, August 22, 2023
Vistagen Appoints Cindy Anderson As Chief Financial Officer; Anderson Succeeds Jerrold Dotson Who Is Retiring After A Distinguished Decade-Long Career With Vistagen, Effective August 21, 2023
Happy Mohamed
Friday, August 11, 2023
VistaGen Therapeutics shares are trading lowe...
Benzinga Newsdesk
Thursday, August 10, 2023
VistaGen Therapeutics Q1 EPS $(0.94) Up From ...
Benzinga Newsdesk
Why Krispy Kreme Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
AffaMed Therapeutics Announces Partner Vistagen Reports Top-Line Results From Phase 3 PALISADE-2 Trial Of Fasedienol Nasal Spray In Social Anxiety Disorder
Happy Mohamed
Why AppLovin Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket
Lisa Levin
$18M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Lisa Levin
Earnings Scheduled For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Vistagen Therapeutics 10%+ Shareholder COMMOD...
Charles Gross
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch